JNDASD
DZ
DM
MRYZJMPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Arcellxarcellx.com  JSJNDA |
Arcellx (now part of Kite, a Gilead company) is a biotechnology research firm founded in 2015 that developed Anito-cel, a cell the | Redwood City, California | 201-1000 | — |
Cabaletta Biocabalettabio.com  SGHHAD |
Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company developing engineered T cell therapies for autoimmune disea | Philadelphia, Pennsylvania | 51-200 | — |
Legend Biotechlegendbiotech.com JSER  BS |
Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel cell therapies for hematolog | Somerset, New Jersey | 1001-5000 | — |
Kite Pharmakitepharma.com  BCLH JT |
Kite, a Gilead Company, is a biotechnology research organization that develops CAR T-cell therapy to treat hematologic malignancie | Santa Monica, California | 1001-5000 | — |
Bmsbms.com MAVS  MS |
Bristol Myers Squibb (BMS) is a global biopharmaceutical company that develops and manufactures new medicines for serious and life | Lawrence Township, New Jersey | 5000+ | — |
Caribou Biosciencescariboubio.com |
Caribou Biosciences is a clinical-stage biopharmaceutical company developing off-the-shelf, allogeneic CAR-T cell therapies using | Berkeley, California | 51-200 | — |
Autolusautolus.com SM  JSX( |
Autolus is a clinical-stage biopharmaceutical company developing CAR T cell therapies for patients with cancer and autoimmune dise | — | — | — |
Novartisnovartis.com MC  PWQT |
Novartis is an innovative medicines company that discovers and commercializes medicines across cardiovascular, renal and metabolic | — | — | — |
Allogene Therapeuticsallogene.com DL  KPSD |
Allogene Therapeutics is a clinical-stage biotechnology company developing investigational allogeneic chimeric antigen receptor T | South San Francisco, California | 201-1000 | — |
Adaptimmuneadaptimmune.com |
Adaptimmune (ADAPY) is a biopharmaceutical company developing cell therapies to treat cancer, with its announced product TECELRA ( | — | — | — |
Gracellbiogracellbio.com |
— | — | — | |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
2seventy bio2seventybio.com |
2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies, operating from Cambridge, Ma | Cambridge, Massachusetts | 201-1000 | — |
CRISPR Therapeuticscrisprtx.com  SGHXGW |
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever appr | Boston, Massachusetts | 201-1000 | — |
Ampersand Biomedicinesampersand.bio |
Ampersand Biomedicines is a biotechnology company developing AND-Body™ therapeutics — programmable, multi-specific medicines that | Boston, Massachusetts | 51-200 | — |
Inhibrxinhibrx.com |
Inhibrx is a biotechnology company building a large and diverse pipeline of optimized biologic therapeutics using a single domain | San Diego, California | 51-200 | — |
Editas Medicineeditasmedicine.com |
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipel | Cambridge, Massachusetts | 51-200 | — |
Pfizerpfizer.com |
Pfizer is one of the world's premier biopharmaceutical companies, developing and manufacturing medicines and vaccines across inter | New York, New York | 5000+ | — |
Genentechgenentech.com |
— | — | — | |
Kyverna Therapeuticskyvernatx.com |
Kyverna is a clinical-stage biopharmaceutical company developing autologous CD19-targeting CAR T-cell therapies to treat B-cell-dr | Emeryville, California | 51-200 | — |
Sparktherapeuticssparktherapeutics.com |
— | — | — | |
Merckmerck.com |
Merck is a research-intensive biopharmaceutical company with more than 130 years of history, developing medicines and vaccines thr | Kenilworth, New Jersey | 51-200 | — |
Amgenamgen.com |
Amgen is a biotechnology pioneer that uses living cells to make biologic medicines, with a research pipeline treating cancer, hear | Thousand Oaks, California | 5000+ | — |
Blueprint Medicinesblueprintmedicines.com |
Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines | Cambridge, Massachusetts | 201-1000 | — |
Cartesian Therapeuticscartesiantherapeutics.com |
Cartesian Therapeutics is a biotechnology company founded in 2016 and headquartered in Rockville, Maryland, that is pioneering pot | Rockville, Maryland | 11-50 | — |
Beam Therapeuticsbeamtx.com |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
Regeneronregeneron.com |
Regeneron is a biopharmaceutical company that invents, develops, and commercializes life-transforming medicines for people with se | Tarrytown, New York | 5000+ | — |
Verve Therapeuticsvervetx.com |
Verve Therapeutics is a wholly owned subsidiary of Eli Lilly and Company developing a new class of genetic medicines for cardiovas | Boston, Massachusetts | 51-200 | — |
Janssenjanssen.com |
— | — | — | |
Cariboubiosciencescariboubiosciences.com |
— | — | — | |
| Run live for more | ||||
Arcellx (now part of Kite, a Gilead company) is a biotechnology research firm founded in 2015 that developed Anito-cel, a cell therapy for cancer, which was acquired by Gilead Sciences in February 2026 ahead of its potential commercial launch.
Companies like Arcellx include Cabaletta Bio, Legend Biotech, Kite Pharma, Bms, Caribou Biosciences. See the full list of 24 competitors and alternatives above.
Arcellx has approximately 201-1000 employees and is in the Biotechnology Research industry.
Arcellx is headquartered in Redwood City, California.
Arcellx operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Arcellx are listed above, including leaders across executive, finance, sales and operations.